Canada· CA-DIN-02329034

CERETEC

A 99mtc-technetium-exametazim markierte zellen product containing exametazime, registered in Canada by GE HEALTHCARE CANADA INC. The same ATC class is registered in 2 of our 19 countries.

ATC V09HA02

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedCERETECATCV09HA02REGISTER NO.CA-DIN-02329034PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

99mtc-technetium-exametazim markierte zellen is registered in 2 of 19 countries.

Countries holding a registration under ATC V09HA02 (99mtc-technetium-exametazim markierte zellen), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 1 of them publish a price we can compare per daily dose

99mtc-technetium-exametazim markierte zellen · ATC V09HA02

2 / 19 countries

  • Canada
  • Czechiaprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
EXAMETAZIME
Manufacturer
GE HEALTHCARE CANADA INC
Country
Canada (CA)
ATC code
V09HA02
ATC class
99mTc-Technetium-Exametazim markierte Zellen
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

99mtc-technetium-exametazim markierte zellen in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All 99mtc-technetium-exametazim markierte zellen products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Medi-Exametazim
  • Belgium · Exametazime Radiopharmacy Laboratory, Stabilised Ceretec
  • Czechia · Brain - Spect Kit, Exametazim Radiopharmacy Laboratorium
  • Germany · Medi-Exametazim
  • Denmark · Ceretec, Medi-Exametazim
  • Spain · Ceretec, Ceretec Estabilizado
  • Finland · Ceretec
  • France · Cerestab, Ceretec
  • United Kingdom (Northern Ireland) · Ceretec, Stabilised Ceretec
  • Greece · Ceretec
  • Hungary · Brain-Spect, Ceretec
  • Italy · Ceretec, Exametascan
  • Lithuania · Ceretec
  • Luxembourg · Medi-Exametazim, Stabilised Ceretec
  • Netherlands · Ceretec, Exametazime Radiopharmacy Laboratory
  • Norway · Ceretec, Exametazime Radiopharmacy Laboratory
  • Portugal · Exametazima Radiopharmacy
  • Sweden · Ceretec Stabilised, Exametazim Radiopharmacy Laboratory
  • Slovenia · Eksametazim Radiopharmacy Laboratory
  • Slovakia · Ceretec

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2e37fb40-c28f-4110-8336-cfc8b27522b5
GET /v1/drugs/2e37fb40-c28f-4110-8336-cfc8b27522b5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02329034",
  "form": "POWDER FOR SOLUTION",
  "class": "Radiopharmaceutical",
  "routes": [
    "INTRAVENOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "V09HA02",
  "schedule": [
    "Schedule C"
  ],
  "drug_code": "81468",
  "strengths": [
    "0.5 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "EXAMETAZIME"
  ],
  "product_categorization": null
}

See everything about 99mtc-technetium-exametazim markierte zellen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.